Capabilities
Active Pharmaceutical Ingredients
Product
Facilities
Finished Dose Formulations
Product
Facilities
Antimicrobial Solutions
Novel Medicine
Featured Portfolio
Antimicrobial Stewardship Program
Exblifep
Research
Fighting AMR
Fighting AMR
Antimicrobial Stewardships
Company
About us
Careers
Our thoughts
Investor
Contact
Contact
Stockexchanges
Review of Credit Rating_September 30, 2021
September 30, 2021
Intimation for Closure of Trading Window_September 30, 2021
September 30, 2021
Disclosure under Regulation 39(3)_September 29, 2021
September 29, 2021
Termination of GDR Agreement_September 25, 2021
September 25, 2021
Intimation under Regulation 30_Transfer of formulations business (IKKT)
September 18, 2021
Newspaper Publication_Unaudited Financial Results_June 30, 2021
August 17, 2021
Scrutinizer Report_28th Annual General Meeting_August 15, 2021
August 15, 2021
Proceedings of AGM_August 13, 2021
August 14, 2021
Outcome of Board Meeting_Unaudited Financial Results_June 30, 2021
August 13, 2021
Notice of Board Meeting_August 13, 2021
August 6, 2021
Statement of Investor Complaints_June 30, 2021
July 21, 2021
Outcome of Board Meeting_July 15, 2021
July 1, 2021
Board Meeting Intimation_July 15, 2021
July 1, 2021
Intimation of Book Closure for 28th AGM
July 1, 2021
Intimation under Regulation 30_July 22, 2021
July 1, 2021
Annual Report 2020-2021 and Notice of 28th AGM
July 1, 2021
Previous
1
...
Next
20 / 36